Concepedia

Author

Carmen Alcalá

Hospital Universitari i Politècnic La FeORCID

Also Known As

C. Alcalá, Carmen Alcala, Carmen Alcalá

34

Publications

1.1K

Citations

14

H-Index

26

Concepts

All Affiliations

Hospital Universitari i Politècnic La FeHospital Clínico Universitario de ValenciaHospital Universitario Doctor PesetHospital General de EldaLudwig-Maximilians-Universität München
CA

About

Carmen Alcalá is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, neurology, and multiple sclerosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

764

2

Neurology

4

4

671

3

Immunology

2

2

79

4

Social Sciences

1

1

606

5

Neuroscience

1

1

606

Carmen Alcalá

×

17

Publications

1.1K

Citations

14

H-Index

YearCitations

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies

Mar Petit‐Pedrol, Thaís Armangué, Xiaoyu Peng,

The Lancet Neurology

2014

606

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis

Sara Gil‐Perotín, Jéssica Castillo-Villalba, Laura Cubas-Núñez,

Frontiers in Neurology

2019

75

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Bonaventura Casanova, Isidro Jarque, Francisco Gascón,

Neurological Sciences

2017

58

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

Carmen Alcalá, Francisco Gascón, Francisco Pérez‐Miralles,

Journal of Neurology

2018

57

CSF chitinase 3-like-1 association with disability of primary progressive MS

Francisco Pérez‐Miralles, Daniel Prefasi, Antonio Garcı́a-Merino,

Neurology Neuroimmunology & Neuroinflammation

2020

35

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies

Francisco Coret, Francisco Pérez‐Miralles, Francisco Gascón,

Multiple Sclerosis Journal - Experimental Translational and Clinical

2018

34

Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe

Carmen Alcalá, Francisco Gascón, Francisco Pérez‐Miralles,

Journal of Neurology

2019

31

Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA <sub>A</sub> receptor encephalitis

Simone M. Brändle, Manuela Cerina, Susanne Weber,

Proceedings of the National Academy of Sciences

2021

31

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

Carmen Alcalá, Carlos Quintanilla‐Bordás, Francisco Gascón,

Journal of Neurology

2022

24

Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease

Carmen Alcalá, F. Pzére-Miralles, Francisco Gascón,

Multiple Sclerosis and Related Disorders

2018

22

Page 1